LAKE FOREST, Ill., June 11, 2012 /PRNewswire/ -- Hospira (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today released an important enhancement to its TheraDoc™ clinical surveillance system designed to support hospital antimicrobial stewardship efforts, with the goal of helping to improve patient outcomes, reduce antimicrobial resistant infections and reduce costs. The new TheraDoc system version 4.5, which further automates the monitoring and reporting of infections and antibiotic use, includes powerful features that can assist pharmacists and infection preventionists in maximizing the benefits of clinical surveillance throughout their organizations.
Improving antibiotic use is a key priority for hospitals nationwide, and antimicrobial stewardship plays a critical role in fighting antimicrobial resistance by ensuring appropriate drug selection, dosing and duration. According to the Centers for Disease Control and Prevention (CDC), studies indicate that nearly 50 percent of antimicrobial use in hospitals is unnecessary or inappropriate, and that the overuse of antibiotics is contributing to the growing challenges posed by Clostridium difficile and other antibiotic-resistant bacteria.
"The upgraded TheraDoc system helps hospitals leverage patient data to improve antibiotic use, combat antimicrobial resistance, and ultimately save lives," said France Pitera, vice president, Clinical Information Technology, Hospira. "The software upgrade also helps hospitals improve antimicrobial utilization reporting -- a result of TheraDoc's early work with the CDC on its Antimicrobial Usage Reporting project. We are committed to being at the forefront of clinical surveillance and reporting, as integrating and exchanging relevant patient information supports efforts to protect patients and improve healthcare quality."The TheraDoc system version 4.5 features a new electronic medication administration record (eMAR) interface that integrates medical administration records into the TheraDoc system, allowing hospitals to monitor antimicrobial utilization using days of therapy or defined daily dose and export this data to the NHSN. The eMAR interface also helps infection preventionists improve patient care by simplifying the process of isolation management.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts